1
00:00:00,530 --> 00:00:05,130
dysregulated map case signaling has been
implicated in a wide range of cancers

2
00:00:05,130 --> 00:00:09,980
and occurs via multiple mechanisms
including activation of receptors and

3
00:00:09,980 --> 00:00:15,240
activating chaos and b-raf mutations
these may lead to increased or

4
00:00:15,240 --> 00:00:19,920
uncontrolled cell proliferation
resistance to a potato sis program cell

5
00:00:19,920 --> 00:00:25,010
death and resistance to chemotherapy
radiotherapy and targeted therapies a

6
00:00:25,010 --> 00:00:29,939
vast array of growth factors exert their
effects by the recruitment and

7
00:00:29,939 --> 00:00:34,340
activation of signaling molecules of
this pathway which include wrath wrath

8
00:00:34,340 --> 00:00:40,649
mech and erk also known as map cake map
case signaling is activated through

9
00:00:40,649 --> 00:00:44,309
binding of a growth factor to the
extracellular domain of the tyrosine

10
00:00:44,309 --> 00:00:50,280
kinase receptor signaling molecules grb2
and sauce our next recruited to the

11
00:00:50,280 --> 00:00:55,110
internal docking site resulting in rass
activation of the membrane the

12
00:00:55,110 --> 00:00:58,800
efficiency and duration of signal
transmission is regulated by the

13
00:00:58,800 --> 00:01:04,739
scaffolding protein kinase suppressor of
rass ksr Raz triggers of phosphorylation

14
00:01:04,739 --> 00:01:10,639
cascade involving wrath mech and erk
proteins leading to erk activation and

15
00:01:10,639 --> 00:01:15,779
translocation to the nucleus once in the
nucleus Ark activates several

16
00:01:15,779 --> 00:01:21,479
transcription factors that mediate gene
expression target genes thus activated

17
00:01:21,479 --> 00:01:29,419
by map case signaling contribute to
higher proliferation and survival

18
00:01:29,419 --> 00:01:37,880
Genentech by oncology is researching new
ways to inhibit map k pathway signaling

